Personal genome scans to cost as little as $399

by Yuliya Talmazan | September 9, 2008 at 12:11 pm
421 views | 2 Recommendations | 5 comments

Photos

23andme Boxes

23andme Boxes

see larger image

uploaded by pablo_marx

Just two years ago, the sequence of the last chromosome was published in "Nature." It took $3 billion in public funding and hundreds of researchers from USA, Canada, UK and other countries to sequence human genome. Considering there are 3 billion base pairs (DNA building blocks) in human genome, it worked out to roughly $1 per base pair. Private venture Celera Genomics headed by scientist and entrepreneur Craig Venter ran a parallel human genome sequencing project but strived for faster and cheaper outcome. The privately funded project took 15 months longer to complete but cost $300 million, a mere fraction in comparison to a whopping $3 billion public-funded project cost. This private genome sequencing was an audacious example of biotechnological entrepreneurship, which revealed the true potential of the biotech industry.

Now the race to assign utility to human genome sequences is on. Companies are on the mission to cut the costs of genome sequencing and analysis to be able to sell genomic information to average consumers.

23andMe, a private biotech company, used to sell genome scanning chips for $1000. Yesterday they announced the price of their genome scan chip will be cut down to match that of an 8GB iPod ($399 to be exact). This sensational price drop of almost 60% is yet another breakthrough in personalized genomics industry. Given the kind of information that the genome scanning chip can provide, one might consider investing.

The chip can help detect predisposition for the following conditions:  
The chip uses 1-2 gene markers to check client’s genome against in order to assess genetic risk for a given condition. The company’s website offers to buy the kit online and even suggests creating a demo account to explore features of the service they offer through the profile of the example family, the Mendels.

Among other things, their new chip can check people for a condition that makes taking some drugs extremely dangerous. If you are G6PD deficient, and unwittingly take the malaria drug primaquine, you'll have a horrible reaction that may include hemolytic anemia and death.

By checking your genetic makeup before taking a new medication, you might be able to avoid that sort of nasty situation. In other words, the new test could give you a lifesaving warning.

Predicting how someone will respond to a drug before they ever take it, just by looking at their genes, is called pharmacogenetics. It is a rather new field, and not ready for prime time yet, but I have a feeling that services like the one offered by 23andMe will greatly accelerate its development.

At some point 23andMe will start asking its clients how well they respond to particular drugs. By relating that information to their customer's genetic data, the small company's researchers may be able to identify new pharmacogenetic markers -- genes that indicate how someone will react to a medication.

23andMe is also tapping into genealogical industry by announcing a new partnership with Ancestry.com. 

As part of this arrangement, customers who have their DNA analyzed for genealogical purposes by Ancestry.com will also have access to ancestry-related content from 23andMe.






recommend This comment thread is now closed
Emilio Lizardo
Emilio Lizardo
flagged this story as Good Stuff

at 12:40 on September 9th, 2008

yuls.source, I like this story. It's good stuff.

I wonder if the insurance companies are interested at all in this technology ?

Not to mention employers ...

0
goolian

just so pleased i could contribute to the article with my image

goolian has contributed a photo to this story.

0
Slippery Devil

This is a remarkable exhibit of the entire human genome. This display is made up pf several backlit walls, all about 14 feet tall !

I took this photo at an exhibition at the "National Science museum London".

Slippery Devil has contributed a photo to this story.

0
sidrodrigues

I'm glad my photo was chosen for this article too! It's the text version of the human genome. Taken at the Wellcome Collection, London.

sidrodrigues has contributed a photo to this story.

0
ensembio

Be very careful with phrases like " help detect predisposition".

Strictly speaking, unless there is 100% relationship between a SNP and the condition, a more precise way to say this is "the chip can detect gene variations that have been correlated with the following conditions".

 

This story was created over 3 months ago, the comment thread is now closed.

What is NowPublic?

NowPublic lets people work together to cover news events around the world.

Find out more

Crowd Power

Emilio Lizardo
First Flagged at 12:40 PM, Sep 9, 2008 by Emilio Lizardo
These members have powered this story:

Most Recommended Stories in World

 

closeSign in to NowPublic

is reporting from